Qualigen Therapeutics Issues CEO Letter to Stockholders with 2021 Outlook,

AS1411: Conduct Phase 2a clinical trial with AS1411 for the treatment of COVID-19. Preclinical research has demonstrated that AS1411 has potent …, AS1411: Conduct Phase 2a clinical trial with AS1411 for the treatment of COVID-19. Preclinical research has demonstrated that AS1411 has potent …, Read More

Scroll to Top